DE69804212D1 - Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate - Google Patents

Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate

Info

Publication number
DE69804212D1
DE69804212D1 DE69804212T DE69804212T DE69804212D1 DE 69804212 D1 DE69804212 D1 DE 69804212D1 DE 69804212 T DE69804212 T DE 69804212T DE 69804212 T DE69804212 T DE 69804212T DE 69804212 D1 DE69804212 D1 DE 69804212D1
Authority
DE
Germany
Prior art keywords
production
intermediate products
substituted indazol
derivatives
indazol derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69804212T
Other languages
English (en)
Other versions
DE69804212T2 (de
Inventor
Stephane Caron
Allen Eisenbeis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE69804212D1 publication Critical patent/DE69804212D1/de
Application granted granted Critical
Publication of DE69804212T2 publication Critical patent/DE69804212T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69804212T 1997-05-08 1998-04-28 Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate Expired - Fee Related DE69804212T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4685897P 1997-05-08 1997-05-08
PCT/IB1998/000647 WO1998050367A1 (en) 1997-05-08 1998-04-28 Processes and intermediates for preparing substituted indazole derivatives

Publications (2)

Publication Number Publication Date
DE69804212D1 true DE69804212D1 (de) 2002-04-18
DE69804212T2 DE69804212T2 (de) 2002-07-25

Family

ID=21945777

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69804212T Expired - Fee Related DE69804212T2 (de) 1997-05-08 1998-04-28 Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate

Country Status (12)

Country Link
US (1) US6011159A (de)
EP (1) EP0983249B1 (de)
JP (1) JP3399546B2 (de)
AR (2) AR015648A1 (de)
AT (1) ATE214373T1 (de)
AU (1) AU6849798A (de)
DE (1) DE69804212T2 (de)
DK (1) DK0983249T3 (de)
ES (1) ES2172882T3 (de)
PT (1) PT983249E (de)
WO (1) WO1998050367A1 (de)
ZA (1) ZA983842B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002304A0 (en) * 1996-05-03 2001-12-31 Pfizer Substituted indazole derivatives and related compounds
ID24942A (id) * 1997-11-04 2000-08-31 Pfizer Prod Inc Senyawa terapi aktif yang berdasarkan penggantian bioisoster katekol dengan indazole pada inhibitor pde4
JP2000198734A (ja) * 1998-12-30 2000-07-18 Pfizer Inc 胃運動性減弱および関連疾患の治療のための運動性増強薬
KR100423899B1 (ko) * 2000-05-10 2004-03-24 주식회사 엘지생명과학 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸
DE102004005172A1 (de) * 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
UA88792C2 (ru) * 2004-11-10 2009-11-25 Таргасепт, Інк. Гидроксибензоатные соли метаникотиновых соединений
EP2133337A1 (de) 2006-05-09 2009-12-16 AstraZeneca AB Salzformen von (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-Penten-2-Amin
TWI389889B (zh) 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1050129C (zh) * 1994-10-20 2000-03-08 美国辉瑞有限公司 二环四氢吡唑并吡啶和其作为药物的应用
AP2001002304A0 (en) * 1996-05-03 2001-12-31 Pfizer Substituted indazole derivatives and related compounds

Also Published As

Publication number Publication date
US6011159A (en) 2000-01-04
JP3399546B2 (ja) 2003-04-21
JP2000513019A (ja) 2000-10-03
ATE214373T1 (de) 2002-03-15
ES2172882T3 (es) 2002-10-01
EP0983249B1 (de) 2002-03-13
AR015648A1 (es) 2001-05-16
AU6849798A (en) 1998-11-27
WO1998050367A1 (en) 1998-11-12
DE69804212T2 (de) 2002-07-25
PT983249E (pt) 2002-08-30
AR016737A1 (es) 2001-07-25
ZA983842B (en) 1999-11-08
EP0983249A1 (de) 2000-03-08
DK0983249T3 (da) 2002-07-08

Similar Documents

Publication Publication Date Title
ATE283264T1 (de) Zwischenprodukte zur herstellung von metallproteinasehemmern
DE69731835D1 (de) Verfahren zur herstellung von zwischenprodukten des florfenicols
DE69822028D1 (de) Verfahren zur Herstellung eines oxidierten Produkts
DE69805145D1 (de) Verfahren zur Herstellung geschmackserzeugender Tabakartikel
DE69934234D1 (de) Verfahren zur herstellung von masa-mehle
DE69826900D1 (de) Verfahren zur Herstellung von Pyridinderivaten
DE69618363D1 (de) Verfahren zur Herstellung von Epsilon-Caprolactam und Epsilon-Caprolactam-Vorläufern
DE59707913D1 (de) Kontinuierliches Verfahren zur Herstellung von gamma- Aminopropyltrialkoxysilanen
DE69619067D1 (de) Verfahren zur Herstellung von 3-Amino-2-oxo-1-Halogenpropan-Derivaten
DE69809828D1 (de) Verfahren zur Herstellung von Nudeln
DE59603916D1 (de) Verfahren zur Herstellung von Imidazo-Benzodiazepin-Derivaten
DE69625253D1 (de) Verfahren zur Herstellung von Imidazochinazolinon-Derivaten
ATE212034T1 (de) Derivate von 5-0-desosaminyl-6-0-methyl erythronolid a, ihre verfahren zur herstellung und verwendung zur herstellung von arzneimitteln
DE69724801D1 (de) Verfahren und zwischenprodukte zur herstellung substituierter chromanolderivate
DE69635421D1 (de) Verfahren zur herstellung von 2-chlorthiazolderivaten
DE69804212D1 (de) Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate
DE59708227D1 (de) Verfahren zur Herstellung von feinstteiligen Kristallisationsprodukten
DE59606485D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69604875D1 (de) Verfahren zur Herstellung von Cyclopentadienylderivaten
DE60021632D1 (de) Verfahren zur gleichzeitigen Herstellung von Maleinsäureanhydrid und dessen hydrogenierten Derivaten
DE59606489D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE59606657D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69611331D1 (de) Verfahren zur Herstellung von S-Phenyl-L-Cystein
DE59606488D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69530408D1 (de) Neue zwischenprodukte und verfahren zur herstellung von pyridin-derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee